Skip to content

Clinical trials

Phase 3 Uveitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis Phase: Phase 3 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20073
20091
201010
20112
20122
20131
20143
20152
20173
20193
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated11
Unknown status3
Withdrawn3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
XOMA (US) LLC4
JHSPH Center for Clinical Trials3
Lux Biosciences, Inc.3
AbbVie (prior sponsor, Abbott)2
Clearside Biomedical, Inc.2
National Eye Institute (NEI)2
Sirion Therapeutics, Inc.2
University of California, San Francisco2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis40
Uveitis, Intermediate19
Uveitis, Posterior18
Panuveitis15
Uveitis, Anterior4
Behcet Syndrome3
Macular Edema3
Arthritis, Juvenile2
Arthritis1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.